A Partner in Health
A new chapter, a new approach. Collaborating with physicians and other healthcare professionals, focusing on R&D and maintaining clinical leadership add up to innovative medical solutions that make a difference.
Work with Us
Join Covidien, where we appreciate your talent, your experience and your passion for your work. Our culture thrives because we invest in our colleagues' growth and reward their efforts.
Visit Us
COV (NYSE)
| Price: | $36.53 |
| Change: | 0.38 |
| Volume: | 485,312 |
Minimum 20 minute delay
-
9/1/2010 7:01:46 AM
Covidien Announces Investor Meeting Agenda
DUBLIN, Sep 01, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the agenda for its investor meeting on Wednesday, September 15, 2010. The event will be held at The Plaza Hotel, Fifth Avenue at Central Park South, New York, NY. A webcast of the presentations will begin at 12:00 pm and the webcast will conclude by 5:00 pm. … -
8/30/2010 7:01:54 AM
Covidien Completes Sale of Sleep Therapy Product Line
DUBLIN, Aug 30, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Sleep Therapy continuous positive airway pressure (CPAP) and Bi-level products to PH Invest, a privately held company located in Luxembourg. Financial terms of the transaction were not disclosed. … -
8/30/2010 7:01:54 AM
Covidien Completes Sale of Specialty Chemicals Business
DUBLIN, Aug 30, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Specialty Chemicals business to an affiliate of New Mountain Capital, L.L.C. for a cash purchase price of approximately $280 million. … -
7/30/2010 7:02:02 AM
Covidien to Present at BMO Capital Markets Conference
MANSFIELD, Mass., Jul 30, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference in New York on Thursday, August 5, 2010. José (Joe) Almeida, President, Medical Devices, will represent the company in a session scheduled at 3:30 p.m. ET. …